Stryker to Showcase New, Combined Foot and Ankle Portfolio at 2021 ACFAS Vegas Scientific Conference

Combined Portfolio Includes Legacy Wright Medical Products

MAHWAH, N.J.–(BUSINESS WIRE)–Stryker, one of the world’s leading medical technology companies, announced today that it will showcase its new, combined foot and ankle portfolio incorporating Wright Medical’s products at the 2021 American College of Foot and Ankle Surgeons (ACFAS) Vegas Scientific Conference from May 18-21, 2021.

“We are dedicated to helping foot and ankle surgeons treat their patients more efficiently while enhancing patient care and excited to showcase our combined portfolio—in person—for the very first time,” said Patrick Fisher, Vice President and General Manager of Stryker’s Foot & Ankle business unit. “We now have the ability to offer an even more robust product offering that includes the legacy Wright product line. We’re pleased to have broadened Stryker’s foot and ankle product portfolio while complementing the full trauma and extremities product offering.”

Stryker acquired Wright Medical in November 2020 and will feature a variety of products from the combined Foot & Ankle portfolio at ACFAS, including:

• Infinity with Adaptis: Total ankle replacement system
• Gravity Synchfix: Syndesmosis fixation device
• Prophecy: Preoperative navigation system
• PROstep MIS: Minimally invasive surgery
• Hoffmann LRF Hexapod: Deformity correction and limb reconstruction
• T2 ICF nail: Intramedullary nailing system
• VariAx 2: Plating system
• Augment: Bone graft
• Ortholoc ™ 2 LapiFuse ™: Triplanar correction system

Stryker will also debut its Allofiber™ Demineralized Bone Fibers, which are used during foot and ankle joint fusion surgeries, during the conference. Allofiber bone fibers are comprised of 100 percent cortical bone and offer putty-like handling and osteoinductivity, and have received early, positive feedback in the operating room. Allofiber does not break apart with irrigation when packed in a surgical site, and its aseptic processing preserves and exposes endogenous growth factors.

Visit Stryker at booth 110 in the exhibit hall or online for registered attendees at www.eventscribe.net/2021/ACFAS2021Digital/login.asp.

About Stryker

Stryker is one of the world’s leading medical technology companies and, together with its customers, is driven to make healthcare better. The company offers innovative products and services in Orthopaedics, Medical and Surgical, and Neurotechnology and Spine that help improve patient and hospital outcomes. More information is available at www.stryker.com.

Follow Stryker’s Trauma & Extremities division on Twitter and LinkedIn.

A surgeon must always rely on his or her own professional clinical judgment when deciding whether to use a particular product when treating a particular patient. Stryker does not dispense medical advice and recommends that surgeons be trained in the use of any particular product before using it in surgery.

The information presented is intended to demonstrate the breadth of Stryker’s product offerings. A surgeon must always refer to the package insert, product label and/or instructions for use before using any of Stryker’s products. Products may not be available in all markets because product availability is subject to the regulatory and/or medical practices in individual markets. Please contact your sales representative if you have questions about the availability of products in your area.

Content ID: CP-BL-14, 05-2021

Contacts

Andrea Sampson, Sampson Public Relations Group

asampson@sampsonprgroup.com
562.304.0301